Product Pathways
Products
GDC-0879
Structure Price and Availability of GDC-0879
Size Price Stock
  Contact Us for GDC-0879
  • Data sheet
  • Details
  • Quality controls
  • Related Products
No.BCP0003 
Product Name:GDC-0879 
Cas No.:905281-76-7 
Apperarnce:off-white solid 

M.Wt: 334.37

Formula: C19H18N4O2

Solubility: Unknown

Purity: >99%

Storage: -20℃ 2 years

 

Surprise price with large stock

High quality with HPLC & NMR Chart
 
Fast delivery about 4-5 working days

 

GDC-0879 is a highly selective, novel potent, orally bioavailable B-Raf inhibitor in various in vitro and cell-based assays with an IC50 estimate of 0.13 nM against purified B-Raf V600E enzyme and a cellular pERK IC50 of 63 nM in the MALME-3M cell line.For this compound, subnanomolar enzyme potency translated into very effective reduction of cellular viability of BRAF-mutant Malme3M cells (EC50 values were 0.75 umol/L for GDC-0879).In GDC-0879-treated mice, both cell line- and patient-derived BRAFV600E tumors exhibited stronger and more sustained pharmacodynamic inhibition (>90% for 8 hours) and improved survival compared with mutant KRAS-expressing tumors.

Whereas GDC-0879–mediated efficacy was associated strictly with BRAFV600E status, MEK inhibition also attenuated proliferation and tumor growth of cell lines expressing wild-type BRAF (81% KRAS mutant, 38% KRAS wild type). The responsiveness of BRAFV600E melanoma cells to GDC-0879 could be dramatically altered by pharmacologic and genetic modulation of phosphatidylinositol 3-kinase pathway activity. These data suggest that GDC-0879–induced signaling changes are dependent on the point of oncogenic activation within the RAS network

Keywords:buy GDC-0879|GDC-0879 supplier|purchase GDC-0879|GDC-0879 cost|GDC-0879 manufactuer|order GDC-0879|GDC-0879 distributor
 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.